{"classes":[{"categories":[{"measurements":[{"comment":"Data was below the limit of quantification.","groupId":"OG001","spread":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"33"}],"units":"Participants"}],"title":"Cycle 1 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.46","value":"23.1"},{"groupId":"OG001","spread":"12.4","value":"31.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"33"}],"units":"Participants"}],"title":"Cycle 1 Day 1, 5 Minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.73","value":"9.50"},{"groupId":"OG001","spread":"5.34","value":"13.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"32"}],"units":"Participants"}],"title":"Cycle 1 Day 2, 24 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.924","value":"5.67"},{"groupId":"OG001","spread":"16.3","value":"12.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"31"}],"units":"Participants"}],"title":"Cycle 1 Day 3, 48 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.41","value":"3.50"},{"groupId":"OG001","spread":"13.4","value":"8.68"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"31"}],"units":"Participants"}],"title":"Cycle 1 Day 5, 96 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.309","value":"0.844"},{"groupId":"OG001","spread":"3.44","value":"2.19"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"31"}],"units":"Participants"}],"title":"Cycle 1 Day 14, 312 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.128","value":"0.149"},{"groupId":"OG001","spread":"0.322","value":"0.395"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"32"}],"units":"Participants"}],"title":"Cycle 2 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"7.56","value":"25.3"},{"groupId":"OG001","spread":"9.80","value":"32.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"30"}],"units":"Participants"}],"title":"Cycle 2 Day 1, 5-minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.19","value":"8.80"},{"groupId":"OG001","spread":"8.05","value":"10.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"10"}],"units":"Participants"}],"title":"Cycle 2 Day 2, 24 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.95","value":"3.70"},{"groupId":"OG001","spread":"16.8","value":"11.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"29"}],"units":"Participants"}],"title":"Cycle 2 Day 3, 48 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.26","value":"2.04"},{"groupId":"OG001","spread":"17.9","value":"9.61"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"27"}],"units":"Participants"}],"title":"Cycle 2 Day 5, 96 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.163","value":"0.116"},{"groupId":"OG001","spread":"0.387","value":"0.491"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"26"}],"units":"Participants"}],"title":"Cycle 3 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.83","value":"23.9"},{"groupId":"OG001","spread":"9.79","value":"31.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"26"}],"units":"Participants"}],"title":"Cycle 3 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.271","value":"0.218"},{"groupId":"OG001","spread":"0.492","value":"0.691"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"21"}],"units":"Participants"}],"title":"Cycle 4 Day 1, Pre-dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.60","value":"22.9"},{"groupId":"OG001","spread":"12.2","value":"30.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"21"}],"units":"Participants"}],"title":"Cycle 4 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.321","value":"0.264"},{"groupId":"OG001","spread":"0.564","value":"0.845"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"21"}],"units":"Participants"}],"title":"Cycle 5 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.32","value":"22.5"},{"groupId":"OG001","spread":"15.1","value":"30.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"21"}],"units":"Participants"}],"title":"Cycle 5 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.351","value":"0.312"},{"groupId":"OG001","spread":"0.699","value":"1.06"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"17"}],"units":"Participants"}],"title":"Cycle 6 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.38","value":"20.3"},{"groupId":"OG001","spread":"16.1","value":"33.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"17"}],"units":"Participants"}],"title":"Cycle 6 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.337","value":"0.327"},{"groupId":"OG001","spread":"0.618","value":"1.04"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"17"}],"units":"Participants"}],"title":"Cycle 7 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.40","value":"17.9"},{"groupId":"OG001","spread":"15.4","value":"32.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"17"}],"units":"Participants"}],"title":"Cycle 7 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"0.565","value":"1.25"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"14"}],"units":"Participants"}],"title":"Cycle 8 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"10.5","value":"35.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"14"}],"units":"Participants"}],"title":"Cycle 8 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"4.55","value":"14.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"Cycle 8 Day 2, 24 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"2.96","value":"9.53"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"Cycle 8 Day 3, 48 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"2.35","value":"6.44"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"title":"Cycle 8 Day 5, 96 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"4.63","value":"3.30"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"Cycle 8 Day 14, 312 Hours Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"11.7","value":"4.37"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"14"}],"units":"Participants"}],"title":"Cycle 9 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"11.3","value":"29.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"Cycle 9 Day 1, 5 Minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"0.455","value":"1.20"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"title":"Cycle 10 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"9.50","value":"35.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"title":"Cycle 10 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"1.57","value":"1.84"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"8"}],"units":"Participants"}],"title":"Cycle 11 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"10.8","value":"35.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"8"}],"units":"Participants"}],"title":"Cycle 11 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"0.665","value":"1.47"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 12 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"10.4","value":"40.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 12 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"11.5","value":"6.28"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 13 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"16.1","value":"33.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 13 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"0.600","value":"1.60"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 14 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"7.92","value":"37.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 14 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"0.542","value":"1.48"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 15 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"10.6","value":"40.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 15 Day 1, 5 minutes Post-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"0.361","value":"1.52"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 16 Day 1, Pre-Dose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"4.70","value":"41.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 16 Day 1, 5 minutes Post-Dose"}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"33"}],"units":"Participants"}],"description":"Blood samples were collected and tested for serum concentrations of brentuximab vedotin antibody-drug conjugate.","dispersionType":"Standard Deviation","groups":[{"description":"Brentuximab vedotin 1.4 mg/kg, 30-minute IV infusion, Day 1 of every 21-day cycle, until there was evidence of disease progression or unacceptable toxicity.","id":"OG000","title":"Brentuximab Vedotin 1.4 mg/kg: Phase 1"},{"description":"Brentuximab vedotin 1.8 mg/kg, 30-minute IV infusion, Day 1 of every 21-day cycle until there was evidence of disease progression or unacceptable toxicity (Up to 16 cycles). Treatment with brentuximab vedotin beyond 16 cycles was permitted at the joint discretion of the sponsor and the investigator for those participants experiencing continued clinical benefit.","id":"OG001","title":"Brentuximab Vedotin 1.8 mg/kg: Phase 1"}],"paramType":"MEAN","populationDescription":"PK-evaluable population was defined as participants with sufficient dosing and PK data to reliably estimate PK parameters. Cycle 2 Day 2 values are collected in phase 1 participants only. Here, number analyzed is number of participants assessed at given time-point. Data summarized together for all participants in brentuximab vedotin 1.8 mg/kg arm.","reportingStatus":"POSTED","timeFrame":"Cycle 1 and 8 pre-dose and 5 minutes, 24, 48, 96 and 312 hours post-dose; Cycle 2 pre-dose, 5 minutes and 24, 48 and 96 hours post-dose; Cycle 3 to 16 pre-dose and 5 minutes post-dose","title":"Antibody-drug Conjugate (ADC) Serum Concentrations (Phase 1 and 2)","type":"SECONDARY","unitOfMeasure":"ug/mL"}